☆ 4.4 Letter

Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma

HAEMATOLOGICA (2019)

Get Full Text
Add to Collection

Journal

HAEMATOLOGICA
Volume 104, Issue 1, Pages E17-E20

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2018.199257

Keywords

-

Categories

Hematology

Funding

  1. Fund for Scientific Research Flanders (FWO)
  2. Ghent University Special Research Fund (BOF)
  3. European Hematology Association (EHA)
  4. Stand up to Cancer (Flemish Cancer Society)
  5. Belgian Foundation Against Cancer (STK)
  6. Kinderkankerfonds (a non-profit childhood cancer foundation under Belgain law)
  7. Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 19186]
  8. Fondazione Umberto Veronesi [2064]
  9. VSC (Flemish Supercomputer Center)

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.